BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
13.94
-1.04 (-6.94%)
Oct 16, 2026, 4:00 PM EDT - Market closed
BlossomHill Therapeutics Market Cap
BlossomHill Therapeutics has a market cap or net worth of $443.08 million as of October 16, 2026. It is the 15,542nd most valuable company in the world and the 2,819th biggest in the United States.
Market Cap
443.08M
Enterprise Value
371.08M
1-Year Change
n/a
Global Rank
Country Rank
#2,819 United States
Category
ChartMarket Cap Chart
Since the IPO on August 7, 2026, BlossomHill Therapeutics's market cap has decreased from $465.30M to $443.08M, a decrease of -4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 443.08M | -6.94% |
| Oct 15, 2026 | 476.14M | -1.83% |
| Oct 14, 2026 | 485.04M | -1.42% |
| Oct 13, 2026 | 492.03M | -10.36% |
| Oct 12, 2026 | 548.93M | -1.20% |
| Oct 9, 2026 | 555.60M | 3.55% |
| Oct 8, 2026 | 536.53M | 1.63% |
| Oct 7, 2026 | 527.95M | -3.93% |
| Oct 6, 2026 | 549.56M | -13.29% |
| Oct 5, 2026 | 633.79M | 1.27% |
| Oct 2, 2026 | 625.84M | 5.92% |
| Oct 1, 2026 | 590.88M | -0.27% |
| Sep 30, 2026 | 592.47M | -12.77% |
| Sep 29, 2026 | 679.24M | 0.14% |
| Sep 28, 2026 | 678.29M | 8.05% |
| Sep 25, 2026 | 627.75M | -3.52% |
| Sep 24, 2026 | 650.64M | -8.37% |
| Sep 23, 2026 | 710.07M | -11.52% |
| Sep 22, 2026 | 802.57M | -5.78% |
| Sep 21, 2026 | 851.84M | 4.12% |
| Sep 18, 2026 | 818.14M | -0.45% |
| Sep 17, 2026 | 821.86M | 2.17% |
| Sep 16, 2026 | 804.40M | 18.40% |
| Sep 15, 2026 | 679.37M | 1.98% |
| Sep 14, 2026 | 666.19M | 4.22% |
| Sep 11, 2026 | 639.23M | -3.02% |
| Sep 10, 2026 | 659.15M | -2.23% |
| Sep 9, 2026 | 674.16M | -4.06% |
| Sep 8, 2026 | 702.66M | 4.18% |
| Sep 4, 2026 | 674.47M | 9.94% |
| Sep 3, 2026 | 613.49M | 3.30% |
| Sep 2, 2026 | 593.87M | 2.05% |
| Sep 1, 2026 | 581.92M | 3.77% |
| Aug 31, 2026 | 560.78M | -6.44% |
| Aug 28, 2026 | 599.39M | -1.21% |
| Aug 27, 2026 | 606.74M | 7.26% |
| Aug 26, 2026 | 565.68M | 0.22% |
| Aug 25, 2026 | 564.46M | 14.91% |
| Aug 24, 2026 | 491.22M | -2.14% |
| Aug 21, 2026 | 501.94M | 3.67% |
| Aug 20, 2026 | 484.17M | -2.29% |
| Aug 19, 2026 | 495.51M | 0.43% |
| Aug 18, 2026 | 493.36M | -1.71% |
| Aug 17, 2026 | 501.94M | 1.24% |
| Aug 14, 2026 | 495.81M | -1.04% |
| Aug 13, 2026 | 501.02M | 0.68% |
| Aug 12, 2026 | 497.65M | -1.69% |
| Aug 11, 2026 | 506.23M | 3.31% |
| Aug 10, 2026 | 489.99M | 5.31% |
| Aug 7, 2026 | 465.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 465.26M |
| Monopar Therapeutics | 464.95M |
| REGENXBIO | 457.14M |
| Arvinas | 455.74M |
| Allogene Therapeutics | 452.59M |
| Oculis Holding AG | 450.03M |
| Eupraxia Pharmaceuticals | 435.64M |
| Prothena Corporation | 428.66M |